Biogen reported $25.08B in Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Acadia Pharmaceuticals ACAD:US $ 612.77M 11.48M
Acorda Therapeutics ACOR:US $ 406.31M 17.83M
ALKERMES ALKS:US $ 1957.42M 20.43M
Amgen AMGN:US $ 59294M 98M
Bayer BAYN:GR € 128794M 3012M
Biogen BIIB:US $ 25081.4M 1467M
Biomarin Pharmaceutical BMRN:US $ 6145.84M 83.13M
Bluebird Bio BLUE:US $ 573.59M 82.52M
Bristol Myers Squibb BMY:US $ 100357M 2677M
Eli Lilly And LLY:US $ 47063.6M 144.3M
Esperion Therapeutics ESPR:US $ 303.98M 38.87M
Gilead Sciences GILD:US $ 62870M 210M
Intercept Pharmaceuticals ICPT:US $ 498.6M 4.76M
Intra Cellular Therapies ITCI:US $ 811.91M 56.67M
Marinus Pharmaceuticals MRNS:US $ 109.38M 31.43M
Moderna Inc MRNA:US 26.04B 1.57B
Neurocrine Biosciences NBIX:US $ 2005.7M 138.8M
Novartis NOVN:VX SF 122910M 2308M
Ptc Therapeutics PTCT:US $ 1804.06M 4.47M
Puma Biotechnology PBYI:US $ 193.65M 7.03M
Regeneron Pharmaceuticals REGN:US $ 27205.8M 857.1M
Sangamo Biosciences SGMO:US $ 617.13M 37.18M
Sarepta Therapeutics SRPT:US $ 2996.85M 59.3M
Seattle Genetics SGEN:US $ 3630.34M 13.65M
Teva Pharmaceutical TEVA:IT 45.93B 1.13B
Ultragenyx Pharmaceutical RARE:US $ 1320.63M 63.4M
United Therapeutics UTHR:US $ 5543.3M 183.5M
Vertex Pharmaceuticals VRTX:US $ 15582.2M 1326.1M
YTE INCY:US $ 5319.04M 264.81M